Metagenomi Receives Award From Cystic Fibrosis Foundation to Explore Novel Gene Editing Systems for Therapeutic Applications for Cystic Fibrosis

EMERYVILLE, Calif.--(BUSINESS WIRE)--Metagenomi, a gene editing company, today announced that it has received an award from the Cystic Fibrosis Foundation to identify and evaluate novel gene editing systems for the development of therapeutics to treat cystic fibrosis. “Cystic fibrosis is a complex, chronic genetic disease and there remains a significant...

Click to view original post